Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Softhread is a private U.S. healthcare technology company developing blockchain- and AI-enabled software platforms for secure data exchange, interoperability, cybersecurity, and workflow orchestration across healthcare and life sciences. Its flagship platform, Chios, is positioned as a decentralized infrastructure for exchanging sensitive clinical data and metadata, including applications in precision health and personalized medicine. The company appears to operate primarily as a health IT and enterprise software vendor rather than a therapeutics developer, so it does not have a traditional drug pipeline. Softhread has received U.S. National Science Foundation SBIR funding and has promoted use cases spanning healthcare, life sciences, and adjacent regulated industries. The company is active and privately held, with headquarters in the Baltimore, Maryland area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Softhread.